B

Bioatla (BCAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Bioatla (BCAB)

BioAtla, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing our novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

  • USD4.15
  • USD4.28
  • USD4.00
  • USD12.15
  • -48.60%
  • --
  • 114.01k
  • 1.49M
  • 170M
  • 2.01
  • -49.90%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.